Viewpoint: 'Building more investors is vital to the Colorado economy'
Quoting from today's posting in the Denver Business Journal:
"Since January 2011,
we’ve created 97,000 jobs and now have 2.4 million jobs in the state — prerecession levels. And we have the fourth-fastest
job growth in the nation. We are continuing to successfully woo a number of industries and we’re enhancing our advanced
industries with a 10-year, $150 million investment.
We are just missing one key piece of the economic pie:
investors. Venture-capital investment is critical to the growth of successful startup companies...
working on creating more funding opportunities. OEDIT, in partnership with the Colorado BioScience Association and
Johnson & Johnson Development Corp., established the Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC)
in 2009. Celebrating the third biennial conference on Sept. 19, RMLIPC will bring together more than 50 investors to Denver
to showcase 30 regional startup companies in the biotech, diagnostic, medical device and pharmaceutical industries. The Rockies
Venture Club, along with the Impact Angel Group, are working their connections with local angel investors and entrepreneurs."
Rocky Mountain Life Science Investor and Partnering Conference Announces Thirty Regional Companies for 2013 Presentation Lineup
Denver, CO, August 12, 2013– Thirty companies from Arizona, Colorado, Montana
and Utah have been chosen to present at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC),
September 18-19, at The Ritz-Carlton in Denver, Colorado. The announcement is made by April Giles, President & CEO of
the Colorado BioScience Association (CBSA), on behalf of the RMLIPC Selection Committee, who says the presenting companies
were selected from more than 60 applicants by a committee of investors and industry experts. 2013 Rocky Mountain
Life Science Investor and Partnering Conference Presenting Companies:
The 2013 Rocky Mountain Life Science Investor and Partnering Conference – spearheaded by the Colorado BioScience
Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception
at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September
19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation
with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis
Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch will be a presentation from Johnson and Johnson Development
Corporation executive leadership. For more information and registration details, visit http://www.RockyMtnBioInvest.com
On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.